Protalix BioTherapeutics, Inc. PLX
2.72
(0.03)
(1.09%)
as of 25 Sep
- Market cap
- $221.6M
- P/E
- 11.3×
Follow PLX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 47.00 | 14.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.68 | 2.55 | 1.88 | 1.39 | 0.96 | 1.68 | 0.89 | 1.33 | 4.29 | 4.63 |
P/FCF ratio |
0.00 | 18.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
69.65 | 34.17 | 34.18 | (25.43) | (7.20) | (14.01) | (13.20) | (11.39) | 5.14 | (5.80) |
P/B ratio |
2.93 | 3.16 | 3.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
2.93 | 3.16 | 3.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.18 | 1.99 | 1.26 | 1.52 | 0.67 | 1.14 | 1.50 | 1.63 | 4.06 | (0.15) |
EV/EBITDA |
0.00 | 20.31 | 6.95 | 0.00 | 0.00 | 9.59 | 0.00 | 0.00 | 0.00 | 0.04 |
EV/Operating CF |
(9.58) | 12.22 | (62.83) | (2.90) | (2.48) | (2.75) | (4.23) | (7.20) | (8.56) | 0.04 |
EV/FCF |
(8.43) | 14.34 | (33.57) | (2.83) | (2.18) | (2.68) | (4.09) | (6.62) | (7.80) | 0.04 |
Quick Ratio |
1.50 | 1.47 | 1.09 | 0.83 | 1.28 | 0.47 | 0.56 | 1.68 | 2.32 | 1.01 |
Current Ratio |
2.51 | 2.34 | 1.54 | 1.38 | 1.86 | 0.64 | 0.81 | 2.09 | 2.75 | 1.09 |
Net Debt/EBITDA |
7.68 | (6.67) | (3.74) | (0.52) | 0.67 | (4.55) | (5.43) | (0.68) | 0.16 | 1.44 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 50.53% | 37.86% | 6.58% | 112.26% | 78.46% | 64.07% | 23.52% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (2.65) | (4.62) | (0.17) | (0.72) | (0.91) | (1.57) | (1.94) |
Asset Turnover |
0.68 | 0.68 | 0.93 | 0.74 | 0.54 | 1.11 | 1.03 | 0.51 | 0.27 | 0.10 |
Operating CF/Net income |
1.82 | 2.96 | (0.16) | 1.67 | 0.37 | 4.00 | 1.06 | 0.29 | 0.12 | 1.09 |
Capex/Depreciation |
(1.12) | (0.98) | (0.79) | (0.45) | (0.37) | (0.14) | (0.14) | (0.16) | (0.23) | (0.32) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (14.44%) | 7.64% | 72.50% | 179.02% | 166.79% | 13.40% | 29.67% | 64.26% | 423.40% | (6,411.57%) | |
| (8.48%) | 3.71% | 11.86% | (23.06%) | (38.96%) | (11.51%) | (34.31%) | (39.68%) | (108.04%) | (32.72%) | |
ROIC |
(19.92%) | 29.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(14.66%) | 7.51% | 28.30% | (87.79%) | (82.45%) | 25.18% | 754.27% | (77.77%) | (175.39%) | (204.52%) |
Average Days of Receivables |
61.17 | 19.88 | 29.38 | 35.14 | 32.76 | 11.61 | 31.37 | 50.41 | 29.80 | 132.57 |
Research and Development Expense of Revenue |
37.10% | 24.29% | 26.10% | 61.61% | 77.53% | 60.68% | 81.58% | 97.34% | 136.80% | 267.51% |
Selling, General and Administrative Expense of Revenue |
22.15% | 22.83% | 22.84% | 24.58% | 33.19% | 17.72% | 18.10% | 31.88% | 54.70% | 101.71% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.35% | 6.09% | 5.26% | 4.38% | 6.19% | 4.97% | 1.53% | 1.50% | 1.60% | 10.74% |
Graham Net Nets |
0.23 | 0.22 | 0.16 | (0.32) | (0.49) | (0.37) | (1.71) | (1.34) | (0.43) | (0.48) |
Graham Number |
0.00 | 0.73 | 1.21 | 1.22 | 1.38 | 1.71 | 11.22 | 12.39 | 18.36 | 8.03 |
Earnings Yield |
(4.88%) | 2.13% | 7.14% | (21.90%) | (74.70%) | (3.86%) | (35.99%) | (61.28%) | (96.59%) | (69.42%) |
Free Cash Flow Yield |
(9.64%) | 5.42% | (2.01%) | (38.59%) | (31.91%) | (25.29%) | (41.06%) | (18.48%) | (12.12%) | (77.32%) |
Revenue per Share |
0.67 | 0.74 | 0.97 | 0.98 | 0.87 | 2.16 | 3.69 | 2.33 | 1.61 | 0.91 |
Operating CF per Share |
(0.15) | 0.12 | (0.02) | (0.52) | (0.23) | (0.90) | (1.30) | (0.53) | (0.76) | (3.17) |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.01) | (0.03) | (0.02) | (0.04) | (0.05) | (0.07) | (0.08) |
Free Cash Flow per Share |
(0.17) | 0.10 | (0.04) | (0.53) | (0.26) | (0.92) | (1.35) | (0.57) | (0.84) | (3.25) |
Cash per Share |
0.39 | 0.48 | 0.66 | 0.46 | 0.88 | 1.32 | 1.20 | 2.57 | 3.90 | 6.24 |
Shareholders Equity per Share |
0.61 | 0.60 | 0.50 | (0.22) | (0.14) | (0.93) | (4.74) | (3.59) | (2.25) | (0.98) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.61 | 0.60 | 0.50 | (0.22) | (0.14) | (0.93) | (4.74) | (3.59) | (2.25) | (0.98) |
Free Cash Flow |
(13.63) | 7.40 | (2.47) | (25.63) | (11.69) | (26.76) | (19.98) | (8.43) | (10.96) | (32.93) |
Working Capital |
40.16 | 34.46 | 24.40 | 12.45 | 28.49 | (30.75) | (7.70) | 27.63 | 39.90 | 5.66 |
Capital Expenditures |
(1.64) | (1.28) | (1.15) | (0.63) | (1.41) | (0.65) | (0.63) | (0.69) | (0.97) | (0.83) |
Net Current Asset Value |
32.56 | 29.87 | 19.07 | (21.55) | (18.03) | (39.25) | (83.23) | (61.03) | (39.02) | (20.34) |
EV/EBIT |
0.00 | 27.07 | 7.92 | 0.00 | 0.00 | 26.47 | 0.00 | 0.00 | 0.00 | 0.04 |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.01 | 0.04 | 0.01 | 0.01 | 0.02 | 0.05 | 0.09 |
Net Profit Margin |
(12.52%) | 5.49% | 12.69% | (31.33%) | (71.92%) | (10.37%) | (33.42%) | (77.27%) | (395.86%) | (319.22%) |
Price to Operating Income |
0.00 | 34.81 | 11.75 | 0.00 | 0.00 | 39.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.28 | 0.29 | 0.30 | 0.76 | 0.98 | 0.87 | 0.67 | 0.55 | 0.29 |
Cash ROIC |
(21.30%) | 5.23% | (8.05%) | (74.39%) | (25.06%) | (193.75%) | 1,565.86% | (42.96%) | (26.00%) | (56.15%) |
Accounts Receivable Turnover |
8.98 | 13.05 | 13.29 | 11.87 | 14.09 | 18.78 | 11.60 | 10.62 | 8.33 | 3.39 |
Accounts Payable Turnover |
1.10 | 1.01 | 1.09 | 0.94 | 0.73 | 0.55 | 0.64 | 0.58 | 1.08 | 0.81 |
Inventory Turnover |
1.15 | 1.21 | 1.28 | 1.13 | 1.05 | 1.02 | 1.30 | 1.13 | 2.33 | 1.53 |
Average Days of Payables |
339.86 | 362.03 | 379.10 | 337.82 | 522.84 | 709.89 | 616.43 | 607.61 | 403.34 | 499.95 |
Days of Inventory on Hand |
347.91 | 318.83 | 302.47 | 313.06 | 400.83 | 439.15 | 273.21 | 336.24 | 187.71 | 227.96 |
Average Receivables |
5.87 | 4.09 | 4.93 | 4.01 | 2.72 | 3.35 | 4.71 | 3.23 | 2.53 | 2.72 |
Average Payables |
24.63 | 24.00 | 21.00 | 20.78 | 22.28 | 19.77 | 16.94 | 16.16 | 14.17 | 10.33 |
Average Inventory |
23.49 | 20.14 | 17.92 | 17.38 | 15.52 | 10.62 | 8.36 | 8.20 | 6.54 | 5.51 |
Average Assets |
77.88 | 78.93 | 70.11 | 64.73 | 70.80 | 56.66 | 53.26 | 66.67 | 77.23 | 89.75 |
Average Common Equity |
45.72 | 38.39 | 11.46 | (8.34) | (16.54) | (48.68) | (61.60) | (41.17) | (19.71) | 0.46 |
Columns are period end dates